Meyka AI API is live for developers.Start building.
Advertisement
Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF (LABU) Stock Competitors & Peer Comparison

See (LABU) competitors and their performances in Stock Market.

LABUAMEX
Financial ServicesAsset Management - Leveraged
$160.26
$18.96(10.58%)
U.S. Market opens in 60h 56m
Advertisement

Peer Comparison Table: Asset Management - Leveraged Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LABU$173.21+4.69%956.6MN/AN/A+0.74%
LACG$8.85-19.01%307.7BN/AN/AN/A
FFEU$90.85+0.48%212.8BN/AN/AN/A
GRAG$5.75-0.43%127BN/AN/AN/A
SOXL$229.65-18.14%77.3B197.84$1.33+0.03%
VTAPX$25.28-0.08%68.5BN/AN/A+3.76%
VFSTX$10.39-0.10%54.8B59.82$0.17+4.48%
VFSUX$10.39-0.10%54.8B59.82$0.17+4.59%
VSBSX$19.39+0.00%33.5BN/AN/A+3.94%
TQQQ$80.72-6.75%30.6B43.68$1.95+0.37%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LABU vs LACG Comparison June 2026

LABU plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LABU stands at 956.6M. In comparison, LACG has a market cap of 307.7B. Regarding current trading prices, LABU is priced at $173.21, while LACG trades at $8.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LABU currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to LACG's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to LACG. This indicates potentially lower risk in terms of short-term price fluctuations for LABU.Check LACG's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions